6,533 followers
New research: Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting—A Multi-Center Observational Study: Background Patients with advanced intrahepatic cholangiocarcinoma (iCCA) have a poor… https://t.co/QH